We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RED:BMERedeia Corporacion SA Analysis

Data as of 2026-03-14 - not real-time

$15.86

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Red Cat Holdings is trading in a bullish technical environment – the price sits above the 20‑day (≈13.67) and 50‑day (≈13.29) SMAs, the 14‑day RSI is in the low 60s, and the MACD line sits comfortably above its signal line with a positive histogram, all reinforced by an increasing volume trend. The stock is priced near the upper end of its 52‑week range (current ≈15.86 vs. resistance ≈18.78) and enjoys a 30% upside potential according to the computed upside/downside metric, while the Fear & Greed Index reads “Greed” at 72.9, indicating strong market appetite; recent headlines note new Black Widow drone orders from an Asia‑Pacific ally and the launch of a 2× leveraged ETF (RCAX) that could amplify buying pressure.
Fundamentally, the company is struggling – gross margin is deeply negative, operating margins are below –180%, and cash flow is out of sync with a sizable cash pile and a high debt‑to‑equity ratio of roughly 9. No dividend is paid, and valuation multiples (negative PE, P/B ≈7.4, price‑to‑sales >250) suggest the shares are overvalued relative to earnings and book value. Volatility is extreme (>112% 30‑day) and beta exceeds 2, flagging substantial market risk, while regulatory and geopolitical exposure in the defense sector adds further uncertainty.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover and positive histogram
  • RSI in the 60s indicating sustained momentum
  • Rising trading volume supporting price advance

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong sector tailwinds from geopolitical tensions
  • Launch of a 2× leveraged ETF increasing investor exposure
  • Support level at $10.80 providing downside cushion

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Negative profitability and cash‑flow trends
  • High debt‑to‑equity ratio and leverage risk
  • Valuation metrics (negative PE, high P/B) suggest overvaluation

Key Metrics & Analysis

Financial Health

Revenue Growth646.40%
P/E Ratio-52.9
Debt/Equity8.85
P/B Ratio7.4
Op. Cash Flow$-68693328
Industry P/E29.1

Technical Analysis

TrendBullish
RSI60.7
Support$10.80
Resistance$18.78
MA 20$13.67
MA 50$13.29
MA 200$10.20
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price$20.75
Upside/Downside30.83%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.38
Volatility112.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.